Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28960111)

Published in Am J Respir Crit Care Med on October 01, 2017

Authors

Peter J Mazzone, Catherine Rufatto Sears, Doug A Arenberg, Mina Gaga, Michael K Gould, Pierre P Massion, Vish S Nair, Charles A Powell, Gerard A Silvestri, Anil Vachani, Renda Soylemez Wiener, ATS Assembly on Thoracic Oncology

Articles by these authors

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49

Preventing complications of central venous catheterization. N Engl J Med (2003) 16.18

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol (2012) 9.76

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83

Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.69

Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet (2003) 4.01

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res (2005) 3.98

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 3.82

Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med (2014) 3.82

PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res (2006) 3.72

Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69

Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest (2003) 3.55

Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 3.46

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36

Pulmonary complications after esophagectomy. Ann Thorac Surg (2002) 3.35

Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA (2011) 3.34

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. J Natl Cancer Inst (2007) 3.25

Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20

Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A (2011) 3.10

Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94

Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest (2004) 2.89

Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest (2012) 2.86

A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer. J Mol Diagn (2010) 2.86

Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol (2009) 2.79

What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest (2002) 2.79

Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.72

Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med (2003) 2.71

American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest (2011) 2.61

Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55

Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.42

Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med (2006) 2.40

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc (2011) 2.39

Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. J Clin Oncol (2012) 2.30

The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest (2014) 2.30

Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 2.19

Predicting lung cancer prior to surgical resection in patients with lung nodules. J Thorac Oncol (2014) 2.17

Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol (2002) 2.17

Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol (2012) 2.14

Lung cancer screening. Am J Respir Crit Care Med (2015) 2.14

Understanding the economic impact of introducing a new procedure: calculating downstream revenue of endobronchial ultrasound with transbronchial needle aspiration as a model. Chest (2012) 2.11

Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med (2007) 2.08

New testing for lung cancer screening. Oncology (Williston Park) (2012) 2.06

Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05

The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02

Lung cancer screening. J Natl Compr Canc Netw (2012) 2.00

Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med (2009) 1.99

Intensive care decision making in the seriously ill and elderly. Crit Care Med (2004) 1.98

A prospective multicenter study of competency metrics and educational interventions in the learning of bronchoscopy among new pulmonary fellows. Chest (2009) 1.97

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol (2006) 1.92

High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics (2008) 1.91

One hundred years of lung cancer. Am J Respir Crit Care Med (2005) 1.90

Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res (2009) 1.86

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res (2005) 1.86

HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci U S A (2010) 1.86

Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85

Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med (2010) 1.84

Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80

What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest (2013) 1.79

Aggressiveness of intensive care use among patients with lung cancer in the Surveillance, Epidemiology, and End Results-Medicare registry. Chest (2014) 1.78

Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res (2005) 1.75

Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.74

Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.72

Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest (2005) 1.69

A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med (2013) 1.69

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes (2005) 1.69

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. Oncotarget (2012) 1.67

Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology (2007) 1.67

Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol (2003) 1.64

Do-not-resuscitate status and observational comparative effectiveness research in patients with septic shock*. Crit Care Med (2014) 1.62

Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res (Phila) (2011) 1.61

Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med (2011) 1.58

Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol (2009) 1.57

Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest (2003) 1.56

Learning experience of linear endobronchial ultrasound among pulmonary trainees. Chest (2014) 1.55

Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest (2011) 1.54

Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Mol Cell Proteomics (2011) 1.54

Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing. J Thorac Oncol (2012) 1.54

Role of STRAP in regulating GSK3β function and Notch3 stabilization. Cell Cycle (2011) 1.54

"Do not resuscitate" decisions in acute respiratory distress syndrome. A secondary analysis of clinical trial data. Ann Am Thorac Soc (2014) 1.53

Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck (2006) 1.52

When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med (2012) 1.51

Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans. Chest (2009) 1.51

Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol (2007) 1.50

Timeliness across the continuum of care in veterans with lung cancer. J Thorac Oncol (2008) 1.49

Adult Bronchoscopy Training: Current State and Suggestions for the Future: CHEST Expert Panel Report. Chest (2015) 1.49

The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) (2012) 1.49

Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model. Exp Lung Res (2005) 1.48

CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol (2005) 1.47

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res (2007) 1.47

SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res (2012) 1.46

Utilization patterns and patient outcomes associated with use of rescue therapies in acute lung injury. Crit Care Med (2011) 1.46